Published in Ann Rheum Dis on November 01, 1968
Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs. Br Med J (1978) 4.29
Pulmonary fibrosis associated with hypersensitivity to gold salts. Br Med J (1976) 2.91
Failure of cytotoxic drugs to suppress immune responses of patients with rheumatoid arthritis. Ann Rheum Dis (1970) 2.42
Myelotoxicity of gold. Br Med J (1976) 1.58
Immunological studies on the mechanism of gold hypersensitivity reactions. Br Med J (1973) 1.50
Gold encephalopathy. J Neurol Neurosurg Psychiatry (1977) 1.15
Depression of bone marrow colony formation in gold-induced neutropenia. Br Med J (1975) 1.11
Pityriasis rosea and discoid eczema: dose related reactions to treatment with gold. Ann Rheum Dis (1992) 0.77
A laboratory test based on determination of cytokine profiles: a promising assay to identify exposition to contact allergens and predict the clinical outcome in occupational allergic contact dermatitis. BMC Immunol (2015) 0.76
The role of hypersensitivity and the immune response in influencing susceptibility to metal toxicity. Environ Health Perspect (1978) 0.75
Gold for rheumatoid arthritis. Br Med J (1971) 0.75
Immunofluorescence of the skin in gold rashes - with particular reference to IgE. Ann Rheum Dis (1977) 0.75
Drug eruptions. Calif Med (1970) 0.75
TISSUE CULTURE STUDIES OF THE HUMAN LYMPHOCYTE. Science (1964) 4.54
Lymphocyte transformation in drug hypersensitivity. Lancet (1967) 2.09
Time of appearance and distribution of cells capable of secondary immune response following primary immunization. Immunology (1967) 1.84
Toxic effects of phenylbutazone with special reference to disorders of the blood. Br Med J (1953) 1.70
The immunological significance in the guinea-pig of in vitro transformation of lymph node, spleen and peripheral blood lymphocytes. Immunology (1968) 1.52
Effect of a gold salt on the immune response. Arthritis Rheum (1967) 1.38
Lymphocyte cultures in drug hypersensitivity. Lancet (1966) 1.37
Delayed thrombocytopenic purpura after diminutive gold therapy. JAMA (1966) 1.31
Prevalence, nature and identification of leukocyte antibodies. N Engl J Med (1958) 1.17
HEMATOLOGICAL COMPLICATIONS OF PHENYLBUTAZONE THERAPY: REVIEW OF THE LITERATURE AND REPORT OF TWO CASES. Can Med Assoc J (1964) 1.13
RETICULOCYTE COUNT IN PATIENTS WITH RHEUMATOID ARTHRITIS, WITH OBSERVATIONS ON THE EFFECT OF GOLD THERAPY ON BONE MARROW FUNCTION. Ann Rheum Dis (1965) 1.07
Phenylbutazone leukopenia. AMA Arch Intern Med (1959) 1.06
Value and complications of gold therapy in rheumatoid arthritis. Acta Rheumatol Scand (1959) 0.96
Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity. Lancet (1971) 7.98
Systemic lupus erythematosus syndrome induced by practolol. Br Med J (1973) 6.59
Failure of cytotoxic drugs to suppress immune responses of patients with rheumatoid arthritis. Ann Rheum Dis (1970) 2.42
Changes in the life-span of circulating small lymphocytes in mice after treatment with anti-lymphocyte globulin. Lancet (1968) 2.21
Mode of action of anti-lymphocyte globulin. I. The distribution of rabbit anti-lymphocyte globulin injected into rats and mice. Immunology (1968) 1.98
Neurological complications in Behçet's syndrome. Brain (1999) 1.68
Anticardiolipin antibodies: occurrence in Behçet's syndrome. Ann Rheum Dis (1984) 1.61
Suppression of Coombs-positive haemolytic anaemia in NZB mice by antilymphocyte globulin. Lancet (1967) 1.57
Chronic myelocytic leukemia. Origin of some lymphocytes from leukemic stem cells. J Clin Invest (1978) 1.55
Anti-lymphocytic antibody and autoimmune disease: a review. Clin Exp Immunol (1969) 1.53
Mode of action of anti-lymphocyte globulin. II. Changes in the lymphoid cell population in rats treated with anti-lymphocyte globulin. Immunology (1968) 1.49
Virus infections of lympho-reticular cells and auto-immune diseases. Transplant Rev (1976) 1.45
Depletion of long-lived lymphocytes in old New Zealand black mice. Clin Exp Immunol (1970) 1.44
Susceptibility of human lymphocyte populations to infection by herpes simplex virus. Immunology (1977) 1.37
Inactivation of myxoviruses by lymphoid cells. J Gen Virol (1973) 1.33
Control mechanisms in infectious mononucleosis. Clin Exp Immunol (1974) 1.29
Effect of anti-lymphocyte globulin on kidney disease in (N.Z.B. x N.Z.W.) F 1 mice. Lancet (1966) 1.27
Lymphocyte abnormalities in Behçet's syndrome. Clin Exp Immunol (1980) 1.20
The Guillain-Barré syndrome following Campylobacter enteritis with recovery after plasmapheresis. J Infect (1983) 1.18
A new manifestation of infection with Epstein-Barr virus. Br Med J (1978) 1.14
Defective B cell function in systemic lupus erythematosus. Clin Exp Immunol (1982) 1.13
Thrombosis in Behçet's disease: a retrospective survey from a single UK centre. Rheumatology (Oxford) (2001) 1.11
Adoptive transfer of the diseases of New Zealand black mice to normal mouse strains. Clin Exp Immunol (1969) 1.08
Studies of the effect of induced immune lymphopenia. I. Enhanced effects of rabbit anti-rat lymphocyte globulin in rats tolerant to rabbit immunoglobulin G. J Immunol (1967) 1.08
Infection and interferon production in systemic juvenile chronic arthritis: a prospective study. Ann Rheum Dis (1984) 1.07
Lymphokine-activated killer cell activity in rheumatoid arthritis. Clin Exp Immunol (1987) 1.05
Inactivation of influenza virus by human lymphocytes. Clin Exp Immunol (1974) 1.04
Herpes simplex virus depresses antibody production by affecting T-cell function. Nature (1980) 1.04
Chlorambucil-induced chromosome damage to human lymphocytes is dose-dependent and cumulative. Lancet (1984) 1.02
Interferon-gamma production by peripheral blood mononuclear cells from patients with Behçet's syndrome. Clin Exp Immunol (1984) 1.01
Radiosensitivity of peripheral blood lymphocytes in autoimmune disease. Int J Radiat Biol Relat Stud Phys Chem Med (1985) 1.01
Fate of herpes simplex virus in lymphocytes from inflammatory joint effusions. i. Failure of the virus to grow in cultured lymphocytes. Ann Rheum Dis (1979) 1.01
Termination of acquired tolerance by administration of small lymphocytes. J Immunol (1967) 1.01
Replication or inactivation of different viruses by human lymphocyte preparations. Infect Immun (1974) 0.99
Cyclosporin A in the treatment of severe Behçet's uveitis. Br J Rheumatol (1987) 0.97
Intensive immunosuppression versus prednisolone in the treatment of connective tissue diseases. Ann Rheum Dis (1982) 0.97
Self-tolerance and autoimmunity. Br Med Bull (1976) 0.97
Defective repair of 0(6)-methylguanine in autoimmune diseases. Lancet (1982) 0.96
Immunodeficiency and general medicine. Br Med J (1980) 0.95
Pregnancy and immunological disorders. Br Med J (Clin Res Ed) (1982) 0.94
The rheumatoid synovial membrane participates in systemic anti-viral immune responses. Clin Exp Immunol (1985) 0.93
Measruement of immunological function in man: interaction between virus and human leukocytes. Proc R Soc Med (1974) 0.93
Fate of herpes simplex virus in lymphocytes from inflammatory joint effusions. ii. Mechanisms of non-permissiveness. Ann Rheum Dis (1979) 0.93
The viral theory of connective tissue diseases: a review. Med Biol (1975) 0.93
Interferon system in patients with systemic juvenile chronic arthritis: in vivo and in vitro studies. Clin Exp Immunol (1983) 0.93
A search for retrovirus infection in systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis (1988) 0.90
2',5'-oligoadenylate synthetase induction in lymphocytes of patients with connective tissue diseases. Ann Rheum Dis (1986) 0.89
Review: method of separating human blood lymphoid cell populations. J Immunol Methods (1973) 0.89
Normal induction and maintenance of tolerance in (NZBxNZW) F1 mice. Clin Exp Immunol (1969) 0.89
Improved graft survival after treatment with Bordetella and anti-lymphocyte serum. Nature (1969) 0.88
Autoimmune disease in inbred mice. Clin Exp Immunol (1967) 0.88
Spontaneous production of B cell growth factors by SLE lymphocytes. Clin Exp Immunol (1987) 0.87
Intensive immunosuppression in intractable rheumatoid arthritis. Br J Rheumatol (1986) 0.87
The treatment of connective tissue diseases with antilymphocyte globulin. Postgrad Med J (1976) 0.86
Cytokine-independent progression of immunoglobulin production in vitro by B lymphocytes from patients with systemic lupus erythematosus. Clin Exp Immunol (1991) 0.86
Nature and diagnosis of food allergy. Proc Nutr Soc (1979) 0.86
Selective immunosuppressive effects of measles virus infection. Clin Exp Immunol (1982) 0.85
Activation of IL-6 production by UV irradiation of blood mononuclear cells from patients with systemic lupus erythematosus. Clin Exp Immunol (1992) 0.85
Malignancies induced by chlorambucil. Cancer Treat Rev (1984) 0.85
Lymphocyte function and virus infections. J Clin Pathol Suppl (R Coll Pathol) (1979) 0.85
Immunopathology of New Zealand Black mice treated with antilymphocyte globulin. Immunology (1971) 0.84
Treatment with acyclovir does not affect orogenital ulcers in Behçet's syndrome: a randomized double-blind trial. Br J Rheumatol (1988) 0.84
Increased sensitivity of lymphocytes from patients with systemic autoimmune diseases to DNA alkylation by the methylating carcinogen N-methyl-N-nitrosourea. Ann Rheum Dis (1988) 0.83
Renal disease in (NZB x NZW)F1 hybrid mice treated with anti-lymphocytic antibody. Clin Exp Immunol (1970) 0.83
Endothelial prostacyclin release in systemic lupus erythematosus. Thromb Haemost (1989) 0.82
Immunity and depression. Br Med J (Clin Res Ed) (1986) 0.82
Immunoregulatory effects of interferon-alpha. I. Interferon-alpha inhibits in vitro antibody synthesis by normal human lymphocytes. Clin Exp Immunol (1985) 0.82
Induction of antibody synthesis in cultures of human lymphoid cells. Int Arch Allergy Appl Immunol (1973) 0.81
Retroperitoneal fibrosis and polyarteritis nodosa successfully treated by intensive immunosuppression. J R Soc Med (1980) 0.81
Inflammatory disorders of muscle. Aetiology. Clin Rheum Dis (1984) 0.80
Lymphocyte responses in juvenile chronic arthritis and Behçet's disease--cell number requirements and effects of glucocorticosteroid therapy. Clin Exp Immunol (1982) 0.80
Rheumatoid arthritis--a virus disease? J Clin Pathol Suppl (R Coll Pathol) (1978) 0.79
Rheumatoid arthritis in a patient with primary hypogammaglobulinaemia. Br J Rheumatol (1993) 0.79
Scleroderma treated with immunosuppressive drugs. Br J Dermatol (1979) 0.79
Rheumatoid arthritis. Aetiology. Br Med J (1970) 0.79
Sister-chromatid exchange frequencies in fibroblasts and lymphocytes of patients with systemic lupus erythematosus. Mutat Res (1987) 0.78
A viral aetiology for juvenile chronic arthritis? Br J Rheumatol (1988) 0.77
Cyclophosphamide induces more chromosome damage than chlorambucil in patients with connective tissue diseases. Q J Med (1986) 0.77
A rare mediastinal tumour presenting with systemic effects due to IL-6 and tumour necrosis factor (TNF) production. Clin Exp Immunol (1995) 0.77
Sensitivity of lymphocytes from patients with systemic lupus erythematosus to the induction of sister chromatid exchanges by alkylating agents and bromodeoxyuridine. Ann Rheum Dis (1987) 0.77
Lymphocyte function and disease. Br Med J (1978) 0.77
Cryoglobulins and the immunopathological manifestations of autoimmune disease. Clin Exp Immunol (1992) 0.76
Removal of lymphocytes in rheumatoid arthritis. Br Med J (Clin Res Ed) (1981) 0.75
Effects of immunosuppression on herpes simplex virus growth in lymphocytes of patients with connective tissue diseases. Ann Rheum Dis (1983) 0.75
Immunoregulatory effects of alpha-interferon. Effects on in-vitro antibody synthesis by lymphocytes from patients with rheumatoid arthritis. Ann Rheum Dis (1985) 0.75
What is clinical immunology? J Clin Pathol (1981) 0.75
Graft versus host diseases: new versions of old problems? Br Med J (Clin Res Ed) (1985) 0.75
Fate of herpes simplex virus in lymphocytes from blood and joint effusions of systemic and pauciarticular juvenile chronic arthritis. Ann Rheum Dis (1983) 0.75
Systemic lupus erythematosus presenting as morbid jealousy. Postgrad Med J (1980) 0.75
Studies in chronic lymphocytic leukaemia II. Lymphocyte markers, cellular and humoral immunity and the effect of treatment. Postgrad Med J (1980) 0.75
Graft-versus-host disease. Br Med J (Clin Res Ed) (1982) 0.75
Infection with Epstein-Barr virus. Br Med J (1979) 0.75